These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29916747)

  • 1. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel circular RNA circ_HN1/miR-628-5p/Ecto-5'-nucleotidase competing endogenous RNA network regulates gastric cancer development.
    Zhang J; Wang F; Zhang H; Cao M
    Bioengineered; 2021 Dec; 12(2):9739-9752. PubMed ID: 34637682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.
    Zheng C; Guo K; Chen B; Wen Y; Xu Y
    Cancer Biomark; 2019; 26(2):193-202. PubMed ID: 31403941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.
    Zhu J; Zeng Y; Li W; Qin H; Lei Z; Shen D; Gu D; Huang JA; Liu Z
    Mol Cancer; 2017 Feb; 16(1):34. PubMed ID: 28158983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
    Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
    Liang YK; Han ZD; Lu JM; Liu ZZ; Zhuo YJ; Zhu XJ; Chen JX; Ye JH; Liang YX; He HC; Zhong WD
    J Cell Biochem; 2018 Sep; 119(9):7245-7255. PubMed ID: 29797600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
    Guo Z; He C; Yang F; Qin L; Lu X; Wu J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1.
    Zhao S; Jie C; Xu P; Diao Y
    J Cell Biochem; 2020 Jan; 121(1):482-488. PubMed ID: 31310382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miR-30d as a novel prognostic maker of prostate cancer.
    Kobayashi N; Uemura H; Nagahama K; Okudela K; Furuya M; Ino Y; Ito Y; Hirano H; Inayama Y; Aoki I; Nagashima Y; Kubota Y; Ishiguro H
    Oncotarget; 2012 Nov; 3(11):1455-71. PubMed ID: 23231923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer.
    Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ
    J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.
    Hirata H; Ueno K; Shahryari V; Deng G; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
    PLoS One; 2013; 8(1):e55502. PubMed ID: 23383207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
    Lin ZY; Chen G; Zhang YQ; He HC; Liang YX; Ye JH; Liang YK; Mo RJ; Lu JM; Zhuo YJ; Zheng Y; Jiang FN; Han ZD; Wu SL; Zhong WD; Wu CL
    Mol Cancer; 2017 Feb; 16(1):48. PubMed ID: 28241827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis.
    Sun Y; Ma J; Lin J; Sun D; Song P; Shi L; Li H; Wang R; Wang Z; Liu S
    Anticancer Drugs; 2021 Oct; 32(9):950-961. PubMed ID: 34016832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
    Yang ZG; Ma XD; He ZH; Guo YX
    Int Braz J Urol; 2017; 43(6):1060-1067. PubMed ID: 28727371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ZFPM2-AS1 Enhances Retinoblastoma Development by Targeting the miR-3612/NT5E Signaling Axis.
    Ai K; Ni W; Li Z
    Crit Rev Eukaryot Gene Expr; 2022; 32(6):69-82. PubMed ID: 35997119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer.
    Hu S; Meng F; Yin X; Cao C; Zhang G
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.